Advances and challenges in translating stem cell therapies for clinical diseases.
Matthay
Michael A
MA
Institute at the University of California, San Francisco, CA, USA. michael.matthay@ucsf.edu
D000818:Animals; D002318:Cardiovascular Diseases / Q000601:surgery; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery; D004195:Disease Models, Animal; D042783:Endothelial Cells / Q000637:transplantation; D005767:Gastrointestinal Diseases / Q000601:surgery; D006801:Humans; D008171:Lung Diseases / Q000601:surgery; D045164:Mesenchymal Stem Cell Transplantation / Q000379:methods; D009369:Neoplasms / Q000601:surgery; D009422:Nervous System Diseases / Q000601:surgery; D039904:Pluripotent Stem Cells / Q000637:transplantation*; D051437:Renal Insufficiency / Q000601:surgery; D033581:Stem Cell Transplantation / Q000379:methods*